Rockwell Medical Past Earnings Performance
Past criteria checks 0/6
Rockwell Medical has been growing earnings at an average annual rate of 24.7%, while the Medical Equipment industry saw earnings growing at 11.4% annually. Revenues have been growing at an average rate of 7.9% per year.
Key information
24.7%
Earnings growth rate
42.1%
EPS growth rate
Medical Equipment Industry Growth | 8.9% |
Revenue growth rate | 7.9% |
Return on equity | -20.3% |
Net Margin | -5.2% |
Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
Recent updates
Rockwell Medical, Inc. Just Reported A Surprise Profit And Analysts Updated Their Estimates
Aug 11Rockwell Medical, Inc.'s (NASDAQ:RMTI) Subdued P/S Might Signal An Opportunity
Jul 12Does Rockwell Medical (NASDAQ:RMTI) Have A Healthy Balance Sheet?
May 08Is Rockwell Medical (NASDAQ:RMTI) A Risky Investment?
Feb 06Rockwell Medical, Inc. (NASDAQ:RMTI) Doing What It Can To Lift Shares
Dec 25Is Rockwell Medical (NASDAQ:RMTI) Using Too Much Debt?
Oct 11Is Rockwell Medical (NASDAQ:RMTI) Weighed On By Its Debt Load?
Jun 02Is There Now An Opportunity In Rockwell Medical, Inc. (NASDAQ:RMTI)?
Oct 25An Intrinsic Calculation For Rockwell Medical, Inc. (NASDAQ:RMTI) Suggests It's 46% Undervalued
Sep 02Rockwell Medical Q2 Earnings Preview
Aug 12Rockwell Medical: Triferic Remains Key Despite Sluggish Growth Profile
Mar 02Rockwell Medical: Down But By No Means Out
Oct 05Rockwell Medical pops 6% on licensing deal for Triferic AVNU in Turkey
Jun 08Health Check: How Prudently Does Rockwell Medical (NASDAQ:RMTI) Use Debt?
Mar 08Some Rockwell Medical, Inc. (NASDAQ:RMTI) Analysts Just Made A Major Cut To Next Year's Estimates
Feb 10How Many Rockwell Medical, Inc. (NASDAQ:RMTI) Shares Do Institutions Own?
Jan 18Dosing underway in Rockwell Medical's late-stage Triferic trial in China
Jan 13Rockwell Medical: Heavily Oversold Company With Big Potential
Jan 11Revenue & Expenses Breakdown
How Rockwell Medical makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
30 Jun 24 | 94 | -5 | 15 | 1 |
31 Mar 24 | 87 | -9 | 15 | 1 |
31 Dec 23 | 84 | -9 | 14 | 1 |
30 Sep 23 | 81 | -9 | 15 | 1 |
30 Jun 23 | 76 | -12 | 16 | 1 |
31 Mar 23 | 76 | -13 | 17 | 2 |
31 Dec 22 | 73 | -19 | 18 | 3 |
30 Sep 22 | 69 | -25 | 18 | 4 |
30 Jun 22 | 66 | -29 | 20 | 5 |
31 Mar 22 | 63 | -32 | 20 | 7 |
31 Dec 21 | 62 | -33 | 21 | 7 |
30 Sep 21 | 62 | -32 | 23 | 7 |
30 Jun 21 | 61 | -32 | 23 | 8 |
31 Mar 21 | 62 | -31 | 22 | 7 |
31 Dec 20 | 62 | -31 | 24 | 7 |
30 Sep 20 | 63 | -30 | 24 | 7 |
30 Jun 20 | 63 | -30 | 25 | 7 |
31 Mar 20 | 62 | -33 | 28 | 8 |
31 Dec 19 | 61 | -34 | 30 | 7 |
30 Sep 19 | 63 | -36 | 31 | 7 |
30 Jun 19 | 64 | -33 | 31 | 6 |
31 Mar 19 | 64 | -35 | 29 | 4 |
31 Dec 18 | 63 | -32 | 23 | 6 |
30 Sep 18 | 61 | -32 | 21 | 6 |
30 Jun 18 | 59 | -32 | 20 | 7 |
31 Mar 18 | 58 | -27 | 21 | 7 |
31 Dec 17 | 57 | -26 | 23 | 6 |
30 Sep 17 | 56 | -22 | 23 | 5 |
30 Jun 17 | 54 | -21 | 24 | 5 |
31 Mar 17 | 54 | -20 | 22 | 6 |
31 Dec 16 | 53 | -20 | 21 | 6 |
30 Sep 16 | 54 | -21 | 21 | 7 |
30 Jun 16 | 56 | -18 | 20 | 7 |
31 Mar 16 | 55 | -16 | 19 | 5 |
31 Dec 15 | 55 | -14 | 19 | 5 |
30 Sep 15 | 56 | -15 | 19 | 5 |
30 Jun 15 | 55 | -17 | 19 | 5 |
31 Mar 15 | 55 | -17 | 20 | 4 |
31 Dec 14 | 54 | -21 | 18 | 8 |
30 Sep 14 | 54 | -23 | 16 | 12 |
30 Jun 14 | 53 | -33 | 16 | 21 |
31 Mar 14 | 53 | -41 | 15 | 31 |
31 Dec 13 | 52 | -49 | 14 | 39 |
30 Sep 13 | 51 | -54 | 14 | 45 |
Quality Earnings: RMTI is currently unprofitable.
Growing Profit Margin: RMTI is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: RMTI is unprofitable, but has reduced losses over the past 5 years at a rate of 24.7% per year.
Accelerating Growth: Unable to compare RMTI's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: RMTI is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (7.2%).
Return on Equity
High ROE: RMTI has a negative Return on Equity (-20.31%), as it is currently unprofitable.